Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
15.07 -0.21 / -1.37%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
15.07 0.00 / 0.00%
 
Volume: 4.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash------21.6M
 
 
Short Term Investment Cash15.8M-30.4M47.1M-72.0M
 
 
 
 
 
Cash & Short Term Investments83.3M52.8M99.9M71.5M
 
 
 
 
 
 
ReceivablesReceivables2.3M2.3M15.7M9.1M
 
 
 
 
 
 
InventoriesInventories193.4K567.3K2.7M6.2M
 
 
 
 
 
 
Current AssetsOther Current Assets3.7M8.3M12.8M8.4M
 
 
 
 
 
Current Assets89.5M64.0M131.0M95.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross6.5M7.5M10.4M11.1M
 
 
 
 
 
Depreciation-4.7M-5.7M-6.7M-7.6M
 
 
 
 
 
Other Assets0.000.000.002.7M
 
 
Total Assets91.3M65.8M134.7M101.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.8M7.6M2.3M3.1M
 
 
 
 
 
Accrued Expenses5.6M2.4M3.7M7.8M
 
 
 
 
 
Other Current Liabilities8.5M6.5M12.6M15.2M
 
 
 
 
 
Other Liabilities15.3M17.3M18.9M25.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0031.1M49.8M
 
 
 
Other Liabilities0.000.000.0018.3K
 
 
Total Liabilities71.0M54.9M85.9M121.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity20.4M10.9M48.9M-20.0M
 
 
 
 
 
Total Shareholder Equity20.4M10.9M48.9M-20.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding100.6M104.0M112.7M114.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account